Clinical Trial Update: Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on mesenchymal stromal cells for sepsis and septic shock across Phase 1 and Phase 2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: TC Erciyes University | Conditions: Sepsis, Septic Shock | Phase 1, Phase 2 | Status: COMPLETED